Literature DB >> 32255827

Ketoconazole-induced transient hypoadrenocorticism in a dog.

Alyssa M Sullivant1, Patty Lathan1.   

Abstract

A 6-year-old, spayed female, mixed breed boxer dog was presented for decreased appetite, polyuria and polydipsia, and lethargy 9 days after treatment with ketoconazole for Malassezia pododermatitis. Ketoconazoleinduced hypoadrenocorticism was confirmed with an adrenocorticotropic hormone (ACTH) stimulation test, and ketoconazole was discontinued. Clinical signs resolved 48 hours after initiation of prednisone, and resolution of glucocorticoid insufficiency was confirmed with a repeat ACTH stimulation test 48 hours after a 10-day course of prednisone. Glucocorticoid insufficiency after administration of a commonly used dermatological dose of ketoconazole has not been previously reported in veterinary medicine but should be considered in patients with adverse effects while receiving ketoconazole. Key clinical message: Iatrogenic hypoadrenocorticism may occur in dogs treated with commonly used dermatological doses of ketoconazole. The disease is likely transient, but steroid supplementation may be required in some patients to resolve clinical signs, especially in the presence of concurrent illness or stress. Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.

Entities:  

Year:  2020        PMID: 32255827      PMCID: PMC7074211     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  13 in total

1.  Treatment of hyperadrenocorticism in dogs: a survey of internists and dermatologists.

Authors:  E N Behrend; R J Kemppainen; T P Clark; M D Salman; M E Peterson
Journal:  J Am Vet Med Assoc       Date:  1999-10-01       Impact factor: 1.936

2.  Medical combination therapies in Cushing's disease.

Authors:  Lucio Vilar; Luciana A Naves; Márcio C Machado; Marcello D Bronstein
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

3.  Persistent adrenal insufficiency secondary to low-dose ketoconazole therapy.

Authors:  T R Best; J K Jenkins; F Y Murphy; S A Nicks; K L Bussell; D L Vesely
Journal:  Am J Med       Date:  1987-03-23       Impact factor: 4.965

Review 4.  Antifungal treatment of small animal veterinary patients.

Authors:  Daniel S Foy; Lauren A Trepanier
Journal:  Vet Clin North Am Small Anim Pract       Date:  2010-11       Impact factor: 2.093

5.  Use of ketoconazole to treat dogs with pituitary-dependent hyperadrenocorticism: 48 cases (1994-2007).

Authors:  Yu-Hsin Lien; Hui-Pi Huang
Journal:  J Am Vet Med Assoc       Date:  2008-12-15       Impact factor: 1.936

6.  Adverse effects of ketoconazole in dogs--a retrospective study.

Authors:  Ursula K Mayer; Katharina Glos; Matthias Schmid; Helen T Power; Sonya V Bettenay; Ralf S Mueller
Journal:  Vet Dermatol       Date:  2008-08       Impact factor: 1.589

7.  Adrenal response in children receiving high doses of ketoconazole for systemic coccidioidomycosis.

Authors:  H Britton; Z Shehab; E Lightner; M New; D Chow
Journal:  J Pediatr       Date:  1988-03       Impact factor: 4.406

8.  Plasma cortisol response to ketoconazole administration in dogs with hyperadrenocorticism.

Authors:  E C Feldman; D S Bruyette; R W Nelson; T B Farver
Journal:  J Am Vet Med Assoc       Date:  1990-07-01       Impact factor: 1.936

9.  Comparison of classic hypoadrenocorticism with glucocorticoid-deficient hypoadrenocorticism in dogs: 46 cases (1985-2005).

Authors:  Ann L Thompson; J Catharine Scott-Moncrieff; Johnna D Anderson
Journal:  J Am Vet Med Assoc       Date:  2007-04-15       Impact factor: 1.936

10.  Evaluation of aldosterone concentrations in dogs with hypoadrenocorticism.

Authors:  M E Baumstark; N S Sieber-Ruckstuhl; C Müller; M Wenger; F S Boretti; C E Reusch
Journal:  J Vet Intern Med       Date:  2013-11-15       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.